Overview
In a changing and expanding world, this is still the only forum designed for QPPVs by QPPVs, now celebrating its 16th year and still going strong.
Back in a face-to-face format, it brings together QPPVs from all over the world to discuss how to harmonise international QPPV roles. Key trends requiring QPPV awareness, input and oversight are discussed in a high-level and neutral approach.
This year’s objectives have been shaped by feedback provided by participants from the past 15 meetings. We will discuss pragmatic approaches to modern technology and how this will impact the QPPV role in multiple regions.
The Forum is continually supported by key regulators and lives from interaction. Take this opportunity to raise questions and bring your challenging issues to the group in an informal and interactive environment.
Featured Topics
- Keynote: 10 Years of Strengthened EU Pharmacovigilance
- International Pharmacovigilance
- Hackathon - Build On The International Piece: What can we do to have harmonization around the globe?
- Pharmacovigilance System Oversight
- Regulators – Inspection Feedback
- True Adverse Reaction or Not: That’s the Question
- Hot Topics: Bitesized Updates
- QPPV Talks
Why should you attend this conference?
Featured
Want to learn more about Global Forum for Qualified Persons for Pharmacovigilance (QPPV)? You've come to the right site!
Program Committee
-
Angela Van Der Salm, PhD, MSc Director PV, Managing partner
DADA Consultancy B.V., Netherlands -
Magnus Ysander, MD EU & UK QPPV & Head Pharmacovigilance Excellence
AstraZeneca, Sweden -
Shahinaz Badr Pharmacovigilance Consultant and PVQA Auditor - EMEA
Pharma Quality Europe, United Arab Emirates -
Vicki Edwards, RPh Vice President, Pharmacovigilance Excellence and International QPPV
Abbvie, United Kingdom -
Gemma Jimenez Sese Senior Director, Deputy EU QPPV
AstraZeneca, Spain -
Maarten Lagendijk, MSc Deputy EU QPPV
MSD, Netherlands -
Elspeth McIntosh, MBA, RN Director
Castle Pharmacovigilance Ltd, United Kingdom -
Katarzyna Swiderek, MPharm, RPh Director, Safety Evaluation Risk Management (SERM)
GlaxoSmithKline, Poland -
Kiernan Trevett, MSc Quality Policy Lead
Genentech, A Member of the Roche Group, United States -
Sophie Radicke, MSc Head of GPvP and Senior Pharmacovigilance Inspector
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom -
Nicolas Tsiakkas, MD Scientific Director
NIKOLAS TSIAKKAS AND CO OE, Greece -
Willemijn van der Spuij, MSc Executive Director, WorldWide Patient Safety International, Europe
Switzerland
Have an account?